ProPhase Labs CEO Ted Karkus Named One of Inc Magazine's 10
Garden City, NY, April 28, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics...
Stay updated with breaking news from Nasdaq Prph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Garden City, NY, April 28, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics...
ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 382,800 shares, a growth of 23.5% from the March 31st total of 309,900 shares. Based on an average trading volume of 45,200 shares, the days-to-cover ratio is […]
GARDEN CITY, NY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a growth oriented and diversified diagnostics,...
ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $9.77 and traded as high as $10.68. ProPhase Labs shares last traded at $10.26, with a volume of 51,993 shares. Analysts Set New Price Targets A number […]
GARDEN CITY, NY, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and...